HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Gender, age, smoking behaviour and plasma clozapine concentrations in 193 Chinese inpatients with schizophrenia.

AbstractAIM:
To study the relationship between age, gender, cigarette smoking and plasma concentrations of clozapine (CLZ) and its metabolite, norclozapine (NCLZ) in Chinese patients with schizophrenia.
METHODS:
Data from a therapeutic drug monitoring programme were analysed retrospectively. One hundred and ninety-three Chinese inpatients with schizophrenia were assessed using clinical data forms. Steady-state plasma concentrations of CLZ and NCLZ were assayed using high-performance liquid chromatography. Comparisons of dosage and plasma CLZ concentrations were undertaken between males (n = 116) and females (n = 77), younger (<or=40 years, n = 82) and older patients (>40 years, n = 111) and current male smokers (n = 50) and nonsmokers (n = 66).
RESULTS:
(i) Plasma CLZ concentrations demonstrated large interindividual variability, up to eightfold at a given dose; (ii) there were significant effects of gender on plasma CLZ concentrations (relative to dose per kg of body weight) with female patients having significantly higher concentrations than males (30.09 +/- 24.86 vs. 19.87 +/- 3.55 ng ml(-1) mg(-1) day(-1) kg(-1); P < 0.001); (iii) there were no significant differences in plasma CLZ concentrations between those patients <or=40 years old and those >40 years; and (iv) there were no significant differences in plasma CLZ concentrations between male smokers and nonsmokers, despite the CLZ dosage for smokers being significantly higher.
CONCLUSIONS:
Plasma CLZ concentrations vary up to eightfold in Chinese patients. Among the patient-related factors investigated, only gender was significant in affecting CLZ concentrations in Chinese patients with schizophrenia, with female patients having higher levels.
AuthorsYi-lang Tang, Peixian Mao, Feng-Min Li, Wenbiao Li, Qi Chen, Feng Jiang, Zhuo-ji Cai, Philip B Mitchell
JournalBritish journal of clinical pharmacology (Br J Clin Pharmacol) Vol. 64 Issue 1 Pg. 49-56 (Jul 2007) ISSN: 0306-5251 [Print] England
PMID17298477 (Publication Type: Journal Article)
Chemical References
  • Antipsychotic Agents
  • norclozapine
  • Clozapine
Topics
  • Adult
  • Age Factors
  • Aged
  • Aged, 80 and over
  • Antipsychotic Agents (blood, therapeutic use)
  • Asian People
  • Clozapine (analogs & derivatives, blood, therapeutic use)
  • Dose-Response Relationship, Drug
  • Female
  • Humans
  • Male
  • Middle Aged
  • Retrospective Studies
  • Schizophrenia (blood, drug therapy)
  • Sex Factors
  • Smoking (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: